<https://ddr-inhibitors-summit.com/program/day-two/>
<http://schema.org/description>
"Discover the program lead by the leaders of DDR, ATR & PARP Inhibitors development from GlaxoSmithKline, Aprea Therapeutics, MIT and more."
<http://ddr-inhibitors-summit.com/program/day-two/>